MARQUITA STEVENSON: Open Payments
NPI 1598420309 · HAMDEN, CT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$430 in 5 payments from 3 companies in 2025. Trend: 2023 $20 · 2024 $275 · 2025 $430
Food & beverage: $430
| Company | Payments | Amount |
|---|---|---|
| Neurocrine BioSciences, Inc. | 2 | $206 |
| Otsuka America Pharmaceutical, Inc. | 2 | $142 |
| ACADIA Pharmaceuticals Inc | 1 | $82 |
Products named: INGREZZA, REXULTI, NUPLAZID.
Industry payments across CT — which companies pay providers there.
